Track the Venus Remedies Limited stock price and the full management transaction log of the company, a publicly traded company based in India. Shares are listed on the IN market, under the oversight of SEBI (PIT + SAST). Operating in the Health Care sector, Venus Remedies Limited has recorded 3 reports. Market capitalisation: €21.2bn. The latest transaction was disclosed on 31 May 2022 (Purchase). Among the most active insiders: PAWAN CHAUDHARY. All data is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
3 of 3 declarations
Venus Remedies Limited 是一家专注于医疗保健和制药领域的公司,提供创新的药物解决方案。该公司在 XBOM 上市。